Nonhuman leukocyte antigen antibodies that have impact in the heart transplant patient

Yogesh N.V. Reddy, Naveen Luke Pereira

Research output: Contribution to journalArticle

Abstract

PURPOSE OF REVIEW: Despite human leukocyte antigen (HLA) matching and monitoring for donor-specific HLA antibodies, antibody-mediated rejection and chronic rejection in the form of allograft vasculopathy and chronic graft dysfunction continue to occur. There has been increasing interest in non-HLA antibodies as mediators of these changes. RECENT FINDINGS: In this review, we discuss the recent literature describing the importance of non-HLA antibodies in organ transplantation and summarize the literature evaluating such antibodies in heart transplantation. SUMMARY: Monitoring of non-HLA antibodies requires additional measurement standardization and correlation of specific antibodies with outcomes. However, there is promise that identification with newer immunoproteomic techniques and therapy toward such antibodies may improve long-term graft outcomes and decrease acute rejection and allograft vasculopathy.

Original languageEnglish (US)
Pages (from-to)279-285
Number of pages7
JournalCurrent opinion in organ transplantation
Volume24
Issue number3
DOIs
StatePublished - Jun 1 2019

Fingerprint

HLA Antigens
Transplants
Antibodies
Allografts
Organ Transplantation
Heart Transplantation
Tissue Donors

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation

Cite this

Nonhuman leukocyte antigen antibodies that have impact in the heart transplant patient. / Reddy, Yogesh N.V.; Pereira, Naveen Luke.

In: Current opinion in organ transplantation, Vol. 24, No. 3, 01.06.2019, p. 279-285.

Research output: Contribution to journalArticle

@article{7e2019410d0f4f1d961444546d0fea8d,
title = "Nonhuman leukocyte antigen antibodies that have impact in the heart transplant patient",
abstract = "PURPOSE OF REVIEW: Despite human leukocyte antigen (HLA) matching and monitoring for donor-specific HLA antibodies, antibody-mediated rejection and chronic rejection in the form of allograft vasculopathy and chronic graft dysfunction continue to occur. There has been increasing interest in non-HLA antibodies as mediators of these changes. RECENT FINDINGS: In this review, we discuss the recent literature describing the importance of non-HLA antibodies in organ transplantation and summarize the literature evaluating such antibodies in heart transplantation. SUMMARY: Monitoring of non-HLA antibodies requires additional measurement standardization and correlation of specific antibodies with outcomes. However, there is promise that identification with newer immunoproteomic techniques and therapy toward such antibodies may improve long-term graft outcomes and decrease acute rejection and allograft vasculopathy.",
author = "Reddy, {Yogesh N.V.} and Pereira, {Naveen Luke}",
year = "2019",
month = "6",
day = "1",
doi = "10.1097/MOT.0000000000000642",
language = "English (US)",
volume = "24",
pages = "279--285",
journal = "Current Opinion in Organ Transplantation",
issn = "1087-2418",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Nonhuman leukocyte antigen antibodies that have impact in the heart transplant patient

AU - Reddy, Yogesh N.V.

AU - Pereira, Naveen Luke

PY - 2019/6/1

Y1 - 2019/6/1

N2 - PURPOSE OF REVIEW: Despite human leukocyte antigen (HLA) matching and monitoring for donor-specific HLA antibodies, antibody-mediated rejection and chronic rejection in the form of allograft vasculopathy and chronic graft dysfunction continue to occur. There has been increasing interest in non-HLA antibodies as mediators of these changes. RECENT FINDINGS: In this review, we discuss the recent literature describing the importance of non-HLA antibodies in organ transplantation and summarize the literature evaluating such antibodies in heart transplantation. SUMMARY: Monitoring of non-HLA antibodies requires additional measurement standardization and correlation of specific antibodies with outcomes. However, there is promise that identification with newer immunoproteomic techniques and therapy toward such antibodies may improve long-term graft outcomes and decrease acute rejection and allograft vasculopathy.

AB - PURPOSE OF REVIEW: Despite human leukocyte antigen (HLA) matching and monitoring for donor-specific HLA antibodies, antibody-mediated rejection and chronic rejection in the form of allograft vasculopathy and chronic graft dysfunction continue to occur. There has been increasing interest in non-HLA antibodies as mediators of these changes. RECENT FINDINGS: In this review, we discuss the recent literature describing the importance of non-HLA antibodies in organ transplantation and summarize the literature evaluating such antibodies in heart transplantation. SUMMARY: Monitoring of non-HLA antibodies requires additional measurement standardization and correlation of specific antibodies with outcomes. However, there is promise that identification with newer immunoproteomic techniques and therapy toward such antibodies may improve long-term graft outcomes and decrease acute rejection and allograft vasculopathy.

UR - http://www.scopus.com/inward/record.url?scp=85066879641&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066879641&partnerID=8YFLogxK

U2 - 10.1097/MOT.0000000000000642

DO - 10.1097/MOT.0000000000000642

M3 - Article

VL - 24

SP - 279

EP - 285

JO - Current Opinion in Organ Transplantation

JF - Current Opinion in Organ Transplantation

SN - 1087-2418

IS - 3

ER -